Figure 7.2. Summary ROC curve, sensitivity and specificity for MASCC studies.

Figure 7.2Summary ROC curve, sensitivity and specificity for MASCC studies

*

NB. The results for Uys et al., 2007 were reported as sensitivity and specificity (without data) and could not therefore be included in the plot above. The sensitivity and specificity are transposed when compared to Table 7.1 as “low risk of adverse event” was the event of interest in these studies.

From: Identification and Assessment: guideline chapter four

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.